192 related articles for article (PubMed ID: 8605319)
1. Treatment of myelogenous leukemia: current status and investigational options.
Kantarjian HM; O'Brien S; Anderlini P; Talpaz M
Blood; 1996 Apr; 87(8):3069-81. PubMed ID: 8605319
[No Abstract] [Full Text] [Related]
2. Interferon-alpha or homoharringtonine as salvage treatment for chronic myeloid leukemia patients who acquire the T315I BCR-ABL mutation.
de Lavallade H; Khorashad JS; Davis HP; Milojkovic D; Kaeda JS; Goldman JM; Apperley JF; Marin D
Blood; 2007 Oct; 110(7):2779-80. PubMed ID: 17881650
[No Abstract] [Full Text] [Related]
3. Homoharringtonine therapy induces responses in patients with chronic myelogenous leukemia in late chronic phase.
O'Brien S; Kantarjian H; Keating M; Beran M; Koller C; Robertson LE; Hester J; Rios MB; Andreeff M; Talpaz M
Blood; 1995 Nov; 86(9):3322-6. PubMed ID: 7579434
[TBL] [Abstract][Full Text] [Related]
4. [Chronic myeloid leukemia. New prospects for marrow autotransplantation].
Carella AM; Carlier P; Nati S; Congiu A; Pierluigi D; Raffo MR
Haematologica; 1991 Jun; 76 Suppl 3():337-51. PubMed ID: 1684348
[No Abstract] [Full Text] [Related]
5. A retrospective single centre study of the outcome of five different therapy approaches in 48 patients with relapse of chronic myelogenous leukemia after allogeneic bone marrow transplantation.
Elmaagacli AH; Beelen DW; Schaefer UW
Bone Marrow Transplant; 1997 Dec; 20(12):1045-55. PubMed ID: 9466277
[TBL] [Abstract][Full Text] [Related]
6. [Interferon alpha in the treatment of chronic myeloid leukemia. Promises, realities, and perspectives].
Steegmann JL; Granados E; Rodríguez-Salvanés F; Casado LF; Giraldo P; Lavilla E; Gómez-Casares MT; Fernández-Contreras E; Odriozola J
Sangre (Barc); 1998 Apr; 43(2):137-46. PubMed ID: 9656775
[No Abstract] [Full Text] [Related]
7. The management of chronic myeloid leukaemia--a case history.
Sureda A; Hernández-Bronchud M
Ann Oncol; 1997 Jan; 8(1):91-6. PubMed ID: 9093713
[No Abstract] [Full Text] [Related]
8. [Interferon-alpha therapy in chronic myelogenous leukemia].
Ohnishi K
Rinsho Ketsueki; 2000 Apr; 41(4):275-9. PubMed ID: 10846454
[No Abstract] [Full Text] [Related]
9. Use of alpha-2a-interferon to treat cytogenetic relapse of chronic myeloid leukemia after marrow transplantation.
Higano CS; Chielens D; Raskind W; Bryant E; Flowers ME; Radich J; Clift R; Appelbaum F
Blood; 1997 Oct; 90(7):2549-54. PubMed ID: 9326220
[TBL] [Abstract][Full Text] [Related]
10. Chronic myelogenous leukemia--update and future directions.
Kantarjian HM; Deisseroth A; Talpaz M
Rev Invest Clin; 1994 Apr; Suppl():118-24. PubMed ID: 7886295
[No Abstract] [Full Text] [Related]
11. Autologous transplantation therapy for chronic myelogenous leukemia.
Bhatia R; Verfaillie CM; Miller JS; McGlave PB
Blood; 1997 Apr; 89(8):2623-34. PubMed ID: 9108379
[No Abstract] [Full Text] [Related]
12. [Interferon-alpha in the treatment of chronic myeloid leukemia].
Guilhot F
Rev Prat; 1999 Mar; 49(5):464-6. PubMed ID: 10358394
[No Abstract] [Full Text] [Related]
13. Quantification of BCR-ABL transcripts in CML patients in cytogenetic remission after interferon-alpha-based therapy.
Martinelli G; Testoni N; Amabile M; Bonifazi F; De Vivo A; Farabegoli P; Terragna C; Montefusco V; Ottaviani E; Saglio G; Russo D; Baccarani M; Rosti G; Tura S
Bone Marrow Transplant; 2000 Apr; 25(7):729-36. PubMed ID: 10745258
[TBL] [Abstract][Full Text] [Related]
14. Autologous hematopoietic stem cell transplantation in chronic myeloid leukemia with different clinical stages.
Gopcsa L; Barta A; Banyai A; Foldi J; Kalasz L; Pajor L; Gidali J; Regeczy N; Paloczi K
Acta Haematol; 2001; 106(3):100-5. PubMed ID: 11713374
[TBL] [Abstract][Full Text] [Related]
15. Chemotherapy and bone marrow transplantation in the treatment of chronic myelogenous leukemia.
Kantarjian HM; Talpaz M
Semin Oncol; 1994 Dec; 21(6 Suppl 14):8-13. PubMed ID: 7992099
[TBL] [Abstract][Full Text] [Related]
16. Clinical course and therapy of chronic myelogenous leukemia with interferon-alpha and chemotherapy.
Kantarjian HM; Giles FJ; O'Brien SM; Talpaz M
Hematol Oncol Clin North Am; 1998 Feb; 12(1):31-80. PubMed ID: 9523225
[TBL] [Abstract][Full Text] [Related]
17. Chronic myelogenous leukemia: a review.
Cortes JE; Talpaz M; Kantarjian H
Am J Med; 1996 May; 100(5):555-70. PubMed ID: 8644769
[TBL] [Abstract][Full Text] [Related]
18. Long-term follow-up results of alpha interferon therapy in chronic myelogenous leukemia at M. D. Anderson Cancer Center.
Kantarjian HM; Talpaz M
Leuk Lymphoma; 1993; 11 Suppl 1():169-74. PubMed ID: 8251891
[No Abstract] [Full Text] [Related]
19. [Chronic myeloid leukemia--treatment].
Stoetzer OJ; Hentrich M; Salat C
Dtsch Med Wochenschr; 2002 Dec; 127(49):2621-4. PubMed ID: 12469275
[No Abstract] [Full Text] [Related]
20. Blast crisis of chronic myelogenous leukemia in long-lasting systemic lupus erythematosus: regression of both diseases after autologous bone marrow transplantation.
Meloni G; Capria S; Vignetti M; Mandelli F; Modena V
Blood; 1997 Jun; 89(12):4659. PubMed ID: 9192793
[No Abstract] [Full Text] [Related]
[Next] [New Search]
